STRUCTURE-ACTIVITY-RELATIONSHIPS OF SELECTED PHENAZINES AGAINST MYCOBACTERIUM-LEPRAE INVITRO

被引：34

作者：

FRANZBLAU, SG ^{[1
]}

OSULLIVAN, JF ^{[1
]}

机构：

[1] UNIV DUBLIN TRINITY COLL,HLTH RES BOARD LABS,DUBLIN 2,IRELAND

来源：

关键词：

D O I：

10.1128/AAC.32.10.1583

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1583 / 1585

页数：3

共 16 条

[1] BARRY VC, 1958, AM REV TUBERC PULM, V78, P62
[2] BROWNE S. G., 1962, LEPROSY REV, V33, P6
[3] BUDDEMEYER E, 1976, CLIN CHEM, V22, P1459
[4] OXIDATION OF PALMITIC ACID BY MYCOBACTERIUM-LEPRAE IN AN AXENIC MEDIUM
FRANZBLAU, SG
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (01) : 18 - 21
[5] BIOPHYSICAL OPTIMA FOR METABOLISM OF MYCOBACTERIUM-LEPRAE
FRANZBLAU, SG
HARRIS, EB
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) : 1124 - 1129
[6] RAPID INVITRO METABOLIC SCREEN FOR ANTILEPROSY COMPOUNDS
FRANZBLAU, SG
HASTINGS, RC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) : 780 - 783
[7] AXENIC INCORPORATION OF [U-C-14] PALMITIC ACID INTO THE PHENOLIC GLYCOLIPID-I OF MYCOBACTERIUM-LEPRAE
FRANZBLAU, SG
HARRIS, EB
HASTINGS, RC
[J]. FEMS MICROBIOLOGY LETTERS, 1987, 48 (03) : 407 - 411
[8] HASTINGS R C, 1968, Leprosy Review, V39, P3
[9] HASTINGS R C, 1988, Clinical Microbiology Reviews, V1, P330
[10] HASTINGS RC, 1988, ANNU REV PHARMACOL, V28, P231